Archive for the ‘Hepatitis C’ Category
Vertex eyes hep C future as it inks $1.5B pact with Alios
Written by on June 13, 2011and Incivek (telaprevir by Vertex/Johnson & Johnson/Mitsubishi Tanabe Pharma) suggest that uptake of the new protease inhibitors will be rapid and that a significant proportion of Hepatitis C (HCV) patients have been delaying treatment in anticipation For too long, viral hepatitis, an epidemic that doesn't necessarily make headlines, has steadily and silently affected the lives [...]
Read the rest of this entry »